✦ LIBER ✦

Circadian modulated continuous infusion of fudr in patients with disseminated renal cell cancer (RCC)

✍ Scribed by RL, Poorter; Bakker, PJM; Kurth, KH; Rietbroek, RC; Biermans-van Leeuwe, DMJ; Veenhof, CHN

Book ID: 123197596
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 160 KB
Volume: 29
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(93)91252-G

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Circadian rhythm modulated 5-FUdR infusi

Circadian rhythm modulated 5-FUdR infusion with megace in the treatment of advanced pancreatic cancer

✍ Robert de W. Marsh; Vani Manyam; Carol Bewsher; Margaret Youngblood 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 427 KB 👁 1 views

## Abstract Thirteen patients with advanced pancreatic carcinoma were treated with circadian rhythm modulated infusion of 5‐FUdR and Megace. Treatment was initiated at a dose of 0.15 mg/kg/day for 14 days every 28 days and was increased or decreased by 0.025 mg/kg/day with each subsequent cycle unt

Simplified chronomodulated continuous in

Simplified chronomodulated continuous infusion of floxuridine in patients with metastatic renal cell carcinoma

✍ Thierry Conroy; Lionnel Geoffrois; Francois Guillemin; Elisabeth Luporsi; Ivan K 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 776 KB

A single-centre experience with continuo

A single-centre experience with continuous intravenous infusion of recombinant interleukin-2 ± lak cells in metastatic renal cell cancer

✍ Besana, C; Borri, A; Bucci, E; Tresoldi, M; Di Lucca, G; Schönheit, A; Citterio, 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 176 KB

7109 Phase 2 results of ABT-869 treatmen

7109 Phase 2 results of ABT-869 treatment in patients with advanced renal cell cancer (RCC) after sunitinib failure

✍ Tannir, N.; Wong, Y.; Kollmannsberger, C.; Ernstoff, M.S.; Perry, D.J.; Appleman 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

135 Pharmacokinetics and pharmacodynamic

135 Pharmacokinetics and pharmacodynamics of teniposide (VM26) coadministered with cyclosporin a (CSA) in patients with metastatic renal cell cancer (RCC)

✍ G. Toffoli; R. Sorio; E. Galligioni; D. Ritossi; A. Colussi; M. Trovo; M. Baiocc 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 284 KB

Safety and efficacy of subcutaneous and

Safety and efficacy of subcutaneous and continuous intravenous infusion rIL-2 in patients with metastatic renal cell carcinoma

✍ Geertsen, P F; Gore, M E; Negrier, S; Tourani, J M; von der Maase, H 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 138 KB